H. Lundbeck A/S announced Thomas (Tom) Gibbs appointed as Executive Vice President and Head of Lundbeck in the United States. He will also be a member of Lundbeck's Executive Management. Tom will be based in Lundbeck's U.S. head office in Chicago, Illinois, and assume the role no later than end of February 2023.

Tom joins Lundbeck from Vectura Inc. where he currently serves as Chief Executive Officer and Global Business Leader. In this role, he established an organization to advance the development and commercialization of their inhaled therapeutics portfolio. Prior to his role at Vectura, Tom held several Chief Commercial Officer roles, developing Commercial strategy and overseeing execution for U.S., Canadian and European markets at pharmaceutical companies with strong central nervous system (CNS) franchises, including a role as Chief Commercial Officer at Sunovion.

He has also served as Head of General Medicines in the U.S. for Takeda. Tom holds a B.S. in Economics and an MBA from the Wharton School, University of Pennsylvania.